NCT01810978

Synbiotics in Infants With Cyanotic Congenital Heart Disease

Efficacy of Synbiotics in Infants With Cyanotic Congenital Heart Disease

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Dr. Sami Ulus Children's Hospital · Academic / Other
• Sex: All
• Age: 1 Day – 3 Months
• Healthy volunteers: Not accepted

Summary

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. The investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Detailed description

Infants with congenital heart disease have more frequent infections and exposures to antibiotics than healthy infants. Probiotics may prevent pathogen colonization in infants with CHD. Therefore, the investigators hypothesized that synbiotics may reduce the rate of sepsis and necrotizing enterocolitis in infants with CHD

Conditions

• Congenital Heart Disease

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Bifidobacterium lactis plus inulin	5 billion unit Bifidobacterium lactis plus 900 mg inulin per day will be given
DIETARY_SUPPLEMENT	Maltodextrin	same amount of maltodextrin per day will be given as placebo

Timeline

• Start date: 2012-10-01
• Primary completion: 2013-04-01
• Completion: 2013-05-01
• First posted: 2013-03-14
• Last updated: 2013-05-09

Locations

1 site across 1 country: Turkey (Türkiye)